InMed Pharmaceuticals (INM) Receivables - Net: 2021-2025
Historic Receivables - Net for InMed Pharmaceuticals (INM) over the last 4 years, with Sep 2025 value amounting to $343,469.
- InMed Pharmaceuticals' Receivables - Net rose 20.64% to $343,469 in Q3 2025 from the same period last year, while for Sep 2025 it was $343,469, marking a year-over-year increase of 20.64%. This contributed to the annual value of $465,104 for FY2025, which is 31.82% up from last year.
- Per InMed Pharmaceuticals' latest filing, its Receivables - Net stood at $343,469 for Q3 2025, which was down 26.15% from $465,104 recorded in Q2 2025.
- Over the past 5 years, InMed Pharmaceuticals' Receivables - Net peaked at $465,104 during Q2 2025, and registered a low of $14,842 during Q3 2021.
- Its 3-year average for Receivables - Net is $278,178, with a median of $284,695 in 2024.
- Per our database at Business Quant, InMed Pharmaceuticals' Receivables - Net skyrocketed by 993.35% in 2023 and then dropped by 29.58% in 2024.
- Quarterly analysis of 5 years shows InMed Pharmaceuticals' Receivables - Net stood at $50,304 in 2021, then skyrocketed by 62.31% to $81,647 in 2022, then surged by 356.69% to $372,870 in 2023, then dropped by 29.58% to $262,569 in 2024, then increased by 20.64% to $343,469 in 2025.
- Its last three reported values are $343,469 in Q3 2025, $465,104 for Q2 2025, and $367,813 during Q1 2025.